Option Care Health to Be Acquired for $32.05 Per Share by CD&R and McKesson
Option Care Health (OPCH) agreed to be acquired by an investor group led by affiliates of Clayton, Dubilier & Rice and McKesson for $32.05 per share in cash. The deal, subject to shareholder and regulatory approvals, is backed by $2.87 billion in equity commitments and debt financing. The transaction aims to accelerate growth and strategic scale.
How this was made
The 30-second read
Why it matters
The acquisition creates a larger integrated platform, potentially improving scale efficiencies and payer negotiations.
Market read
The deal is a material M&A event in the U.S. healthcare sector, likely moving OPCH stock toward the $32.05 offer price and prompting modest reassessment of McKesson's balance sheet.
What to watch
Potential antitrust concerns and integration risks could affect long‑term value.
Background
Option Care Health (OPCH) operates a network of home health and hospice facilities; McKesson is a major healthcare distributor and services provider.
Ticker impact
Option Care Health disclosed a definitive merger agreement to be acquired at $32.05 cash per share, a new primary M&A announcement.
upward pressure as the stock trades toward $32.05 per share
The cash offer represents a premium to current trading levels; arbitrage traders will bid up the price.
McKesson is a lead investor in the consortium acquiring Option Care Health, making it a direct party to the transaction.
slight pressure or flat as the market assesses financing impact
The deal involves a $2.87 B equity commitment; impact on McKesson's balance sheet is limited relative to its size.
Market effects
Consolidation in the home health and post‑acute care sector may spur further M&A activity.
U.S. healthcare services market sees increased M&A scrutiny.
Limited to U.S. healthcare investors, but signals private‑equity appetite for sector.
Counterpoint
If regulatory approvals stall, the deal could be delayed, capping upside for OPCH.
Key entities
- CompanyOption Care Health
Target of the acquisition, ticker OPCH.
- CompanyMcKesson
Lead investor in the acquiring consortium, ticker MCK.
- Private EquityClayton, Dubilier & Rice
Co‑lead investor in the acquisition consortium.
